Bone marrow suppressing agents
US4976950A · kind A · utility
29Cited by
5References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 1989 |
| Grant date | Dec 11, 1990 |
| Priority date | — |
| Expiry date | Nov 13, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2121/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a method for suppressing bone marrow which comprises administering to a mammal at least one bone marrow suppressing complex of a radionuclide selected from the group consisting of Samarium-153, Gadolinium-159, Holmium-166 and Yttrium-90 and at least one macrocyclic aminophosphonic acid ligand containing the 1,4,7,10-tetraazacyclododecane moiety, or a physiologically acceptable salt thereof. Suitable compositions for use in this method are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.